NYSE:CVS - CVS Health Stock Price, Forecast & News

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Thursday, January 2nd. Shareholders of record on Thursday, January 23rd will be paid a dividend of $0.50 per share on Monday, February 3rd. This represents a $2.00 annualized dividend and a yield of 2.70%. The ex-dividend date is Wednesday, January 22nd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) issued its earnings results on Wednesday, November, 6th. The pharmacy operator reported $1.84 earnings per share for the quarter, topping analysts' consensus estimates of $1.77 by $0.07. The pharmacy operator had revenue of $64.81 billion for the quarter, compared to analyst estimates of $62.99 billion. CVS Health had a return on equity of 15.45% and a net margin of 1.83%. CVS Health's revenue was up 36.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.73 EPS. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for CVS Health.

CVS Health updated its FY19 earnings guidance on Wednesday, November, 6th. The company provided EPS guidance of $6.97-7.05 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.98.

24 equities research analysts have issued twelve-month price targets for CVS Health's shares. Their forecasts range from $61.00 to $97.00. On average, they expect CVS Health's stock price to reach $77.43 in the next year. This suggests a possible upside of 4.6% from the stock's current price. View Analyst Price Targets for CVS Health.

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 6 hold ratings, 17 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Media headlines about CVS stock have been trending somewhat positive on Thursday, InfoTrie reports. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. CVS Health earned a media sentiment score of 1.6 on InfoTrie's scale. They also gave media coverage about the pharmacy operator a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for CVS Health.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Covetrus (CVET), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Diplomat Pharmacy (DPLO), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Cisco Systems (CSCO), NVIDIA (NVDA), Alibaba Group (BABA), Home Depot (HD), Verizon Communications (VZ), Johnson & Johnson (JNJ), Bank of America (BAC) and Intel (INTC).

CVS Health's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Hexavest Inc. (0.09%), SPF Beheer BV (0.09%), Artemis Investment Management LLP (0.06%), Janney Montgomery Scott LLC (0.06%), Country Trust Bank (0.05%) and Gateway Investment Advisers LLC (0.05%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, Helena Foulkes, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Troyen A Brennan and Vost Collin. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Rhenman & Partners Asset Management AB, Coronation Fund Managers Ltd., Commerzbank Aktiengesellschaft FI, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Janney Montgomery Scott LLC, Hexavest Inc. and Loring Wolcott & Coolidge Fiduciary Advisors LLP MA. Company insiders that have sold CVS Health company stock in the last year include Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Larry J Merlo and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was bought by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Artemis Investment Management LLP, Johanson Financial Advisors Inc., Zurcher Kantonalbank Zurich Cantonalbank, Corbenic Partners LLC, F&V Capital Management LLC, Sanders Morris Harris LLC and Country Trust Bank. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $74.01.

CVS Health has a market capitalization of $96.28 billion and generates $194.58 billion in revenue each year. The pharmacy operator earns $-594,000,000.00 in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 295,000 workers across the globe.View Additional Information About CVS Health.

The official website for CVS Health is http://www.cvshealth.com/.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]